Ruirong Yuan
-
- PARP inhibition in cancer therapy 2
- Hematology top 10%
- Erythropoietin and Anemia Treatment 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Lymphoma Diagnosis and Treatment 2
-
- PI3K/AKT/mTOR signaling in cancer 3
- Cancer therapeutics and mechanisms 1
- Protein Degradation and Inhibitors 1
-
- Renal cell carcinoma treatment 2
- Co-authors
- Andrea KayWilliam J. BergDavid LebwohlWei LüPeter C. DowlingYasuhiro MaedaDelong LiuJun Wang
- Cited by
- OncologyHematologyGenetics
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Ruirong Yuan
11 papers receiving 462 citations
Peers
Comparison fields: 5 of 65
- Oncology 204
- Hematology 76
- Genetics 54
- Pathology and Forensic Medicine 75
- Immunology 76
Countries citing papers authored by Ruirong Yuan
This map shows the geographic impact of Ruirong Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruirong Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruirong Yuan more than expected).
Fields of papers citing papers by Ruirong Yuan
This network shows the impact of papers produced by Ruirong Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruirong Yuan. The network helps show where Ruirong Yuan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruirong Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2017 | 82 | |
| 3 | 2015 | 22 | |
| 4 | 2014 | 21 | |
| 5 | 2011 | 3 | |
| 6 | 2011 | 26 | |
| 7 | 2010 | 12 | |
| 8 | 2010 | 22 | |
| 9 | 2010 | 14 | |
| 10 | 2009 | 188 | |
| 11 | 2008 | 78 |
About Ruirong Yuan
Ruirong Yuan is a scholar working on Hematology, Genetics and Oncology, having authored 11 papers that have together received 470 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), Erythropoietin and Anemia Treatment (2 papers), Renal cell carcinoma treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), PARP inhibition in cancer therapy (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer therapeutics and mechanisms (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Oncology (204 citations), Hematology (76 citations) and Genetics (54 citations). Ruirong Yuan has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Andrea Kay, William J. Berg, David Lebwohl, Wei Lü, Peter C. Dowling, Yasuhiro Maeda, Delong Liu, Jun Wang, Wenru Song and Zihai Li. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.